Other pharma spin-offs, as when Switzerland's Novartis hived off its generics unit or America's Pfizer sold its animal-health arm, have worked out well.

其他制药公司的分拆， 如瑞士的诺华公司剥离其仿制药部门或美国的辉瑞公司出售其动物保健部门，都取得了良好的效果。